Home › Funds › Soleus Capital Management, L.P. › CAPR

Soleus Capital Management, L.P. position in CAPR

CAPRICOR THERAPEUTICS INC COM NEW · Health Care

Soleus Capital Management, L.P. reported holding 761,737 shares of CAPR (CAPRICOR THERAPEUTICS INC COM NEW) in its Q2 2026 13F filing — a position valued at US$18.3M, representing 0.63% of its reported portfolio and ranking #43 among its reported holdings. Soleus Capital Management, L.P. has disclosed CAPR holdings in 2 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)761.74K sh
Reported value held$18.34M
Portfolio Weight0.63%
First reportedQ4 2025
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Soleus Capital Management, L.P.'s CAPR position evolved

Soleus Capital Management, L.P. first disclosed a stake in CAPR in Q4 2025 at 646,390 shares (US$18.7M). Across 2 filings, Soleus Capital Management, L.P. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 761,737 shares valued at US$18.3M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 646.39K $18.65M New
Q2 2026 761.74K $18.34M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CAPR and 13F data

CAPR (CAPRICOR THERAPEUTICS INC COM NEW) is a Health Care company. 64 other funds we track also report a position in CAPR — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$98.7M), MONTANOVA CAPITAL, LLC (US$98.6M), RA CAPITAL MANAGEMENT, L.P. (US$36.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CAPR

All CAPR fund holders →

FAQ

How long has Soleus Capital Management, L.P. held CAPR?

Soleus Capital Management, L.P. has disclosed CAPR holdings in 2 of the last 3 reported quarters, going back to Q4 2025.

What is Soleus Capital Management, L.P.'s current position in CAPR?

As of Q2 2026, Soleus Capital Management, L.P. holds 761.74K shares of CAPR (CAPRICOR THERAPEUTICS INC COM NEW), valued at $18.34M, representing 0.63% of its reported portfolio and ranking #43.

Has Soleus Capital Management, L.P. been buying or selling CAPR?

In the latest 13F filing (Q2 2026), Soleus Capital Management, L.P. newly opened its position in CAPR.

Which other funds hold CAPR?

Other major institutional holders of CAPR include TANG CAPITAL MANAGEMENT LLC, MONTANOVA CAPITAL, LLC, RA CAPITAL MANAGEMENT, L.P., among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.